Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA ...

The following is a summary of “Oral Capsule FMT Combined With Bezlotoxumab Is a Successful Rescue Protocol Following Failure ...

Researchers in Nova Scotia led by Dalhousie University's Christopher McMaster have developed new treatments for superbugs — bacteria that no longer respond to current medications. His team ...

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

December 10th 2024EP. 5: Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections The panelist discusses Rebyota, a treatment approved by the FDA for preventing ...

Depression, anxiety, and ADHD present with different symptoms. Doctors may prescribe different medications to treat each one. They can also recommend medications to treat multiple mental health ...

An Innovative Approach to Pain Management Current medications used to treat chronic abdominal pain often rely on opioids. However, opioids can cause severe side effects such as addiction ...

Diagnosis and treatment of CDI represents a challenge to the clinician. As recommended by several guidelines, a key measure for treating CDI ideally includes the discontinuation of concurrent ...

If they don't help, your doctor can prescribe a medication that boosts saliva production called Salagen. Finally, promising new treatments are being studied. Scientists are working on ways to ...